AI assistant
ROSSARI BIOTECH LIMITED — Call Transcript 2022
Feb 12, 2022
59144_rns_2022-02-12_9c7f58ac-1926-466c-af46-159c33d4cea6.pdf
Call Transcript
Open in viewerOpens in your device viewer
February 12, 2022
| DCS-CRDBSE LimitedFirst Floor, New Trade WingRotunda Building, Phiroze Jeejeebhoy TowersDalal Street, Fort Mumbai 400 023Fax No.2272 3121/2037/2039Stock Code: 543213 | Listing ComplianceNational Stock Exchange of India Ltd.Exchange Plaza, 5thFloorPlot No.C/1, ‘G’Block, Bandra- KurlaComplexBandra East Mumbai 400 051Fax No.2659 8237/8238Stock Code: ROSSARI |
|---|
Dear Sir/Madam,
Sub: Intimation of Earnings Conference Call for investors and analysts for Q3 & 9M FY22.
Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our letter dated January 28, 2022, we hereby intimate that an earnings conference call for investors and analysts is being organized by the Company on Tuesday, February 15, 2022 at 05:30 P.M. IST.
The conference call will be initiated with a brief management discussion on the results for quarter and nine months ended December 31, 2021 followed by an interactive Question & Answer session.
Invite in this regard is enclosed for your information and record.
The same may please be taken on record and suitably disseminated to all concerned.
Thanking you,
Yours Sincerely, For Rossari Biotech Limited
==> picture [74 x 47] intentionally omitted <==
==> picture [56 x 55] intentionally omitted <==
_______________________ Parul Gupta Company Secretary & Compliance Officer Membership No.: A38895
Encl.: as above
==> picture [127 x 72] intentionally omitted <==
Rossari Biotech Limited
Q3 & 9M FY22 Earnings Conference Call
Tuesday, February 15, 2022 at 5:30 p.m. IST
Rossari Biotech Limited (Rossari) will host a conference call for investors and analysts on Tuesday, February 15, 2022 at 5:30 pm IST.
The conference call will be initiated with a brief management discussion on the Q3 & 9M FY22 results, to be declared on Monday, February 14, 2022, followed by an interactive Question & Answer session.
Senior Management team of the Company will be present to address the call.
Dial-in details are as follows:
| Timing | 5:30 p.m. IST on Tuesday, February 15, 2022 |
|---|---|
| Universal dial-in | + 91 22 6280 1141 / 7115 8042 |
| Hong Kong Local Access Number | 800 964 448 |
| Singapore Local Access Number | 800 101 2045 |
| UK Local Access Number | 0 808 101 1573 |
| USA Local Access Number | 1 866 746 2133 |
| To enable participants to connect to the conference call | |
| without having to wait for an operator, please register | |
| at the below mentioned link: | |
| Pre-registration (Zero wait time to join | |
| the call) |
Please dial the below number 5-10 minutes prior to the scheduled start to ensure that you are connected to the call in time.
Page | 1
About Rossari:
Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a Speciality-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, India, the Company operates strategically located manufacturing facilities at Silvassa and Dahej. The Company offers tailor-made solutions for Home, Personal Care and Performance chemicals (HPPC), Textile speciality chemicals and Animal Health and Nutrition (AHN). With differentiated product offerings, Rossari caters to an array of applications across FMCG, Home care, Industrial Cleaning, Personal Care, Textile Speciality Chemicals, Performance Chemicals, the Animal Health and Nutrition and Pet Care businesses. The Company has an extensive and a dedicated network of distributors spread all over India.
For more information, please visit www.rossari.com OR contact:
Manasi Nisal Anoop Poojari / Aesha Shah Rossari Biotech Limited CDR India Tel: +91 22 6123 3800 Tel: +91 98330 90434 / 9867250569 Email: [email protected] Email: [email protected] [email protected]
DISCLAIMER:
Certain statements that may be made or discussed at the conference call may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and overseas, tax laws, import duties, litigation, labour relations etc. Actual results might differ substantially from those expressed or implied. Rossari Biotech Ltd will not be in any way responsible for any action taken based on such statements and discussions; and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.
Page | 2